Dovobet® ointment under occlusion overnight for troublesome scalp psoriasis [1]

Acta Dermato-Venereologica

Volumn 86, Issue 1, 2006, Pages 57-58

  Downs, Anthony M R ^a  

^a ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE DIPROPIONATE PLUS CALCIPOTRIOL; STEROID; BETAMETHASONE; BETAMETHASONE DIPROPIONATE; BETAMETHASONE-17,21-DIPROPIONATE; CALCIPOTRIOL; CALCITRIOL; DERMATOLOGICAL AGENT; DRUG DERIVATIVE;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; LETTER; MALE; PRIORITY JOURNAL; PSORIASIS; RECURRENCE RISK; TREATMENT OUTCOME; CLINICAL TRIAL; DRUG COMBINATION; MIDDLE AGED; OINTMENT; SKIN DISEASE; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; BETAMETHASONE; CALCITRIOL; DERMATOLOGIC AGENTS; DRUG COMBINATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; OINTMENTS; PSORIASIS; SCALP DERMATOSES; TREATMENT OUTCOME;

EID: 33744742913     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/00015550510042877     Document Type: Letter

References (10)

1. van der Kerkhof PCM, Franssen EJ. Psoriasis of the scalp. Am J Clin Dermatol 2001; 2: 159-165.
2. Koo J. Vitamin D and scalp psoriasis. Cutis 2002; 70: 21-24.
3. Guenther L, Cambazard F, van der Kerkhoff PCM, Snellman E, Kragballe K, Chu AC, et al. Efficacy and safety of a new combination of calcipotriol and betamethasone diproprionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial. Br J Dermatol 2002; 147: 316-323.
4. Douglas WS, Poulin Y, Decroix J, Ortonne JP, Mrowietz U, Gulliver W, et al. A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone diproprionate or calcipitriol in psoriasis vulgaris. Acta Derm Venereol 2002; 82: 131-135.
5. Papp KA, Guenther L, Boyden B, Larsen FG, Harumi RJ, Guilhou JJ, et al. Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis. J Am Acad Dermatol 2003; 48: 48-54.
6. Kauffmann R, Bibby AJ, Bissonnette R, Cambazard F, Chu AC, Decroix J, et al. A new calcipotriol/betamethasone diproprionate formulation (Daivobet™) is an effective once-daily treatment for psoriasis vulgaris. Dermatology 2002; 205: 389-393.
7. Molin L, Cutler TP, Helander I, Nyfors B, Downes N. Comparative efficacy of calcipotriene (MC 903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis: a randomised, double-blind, parallel group multicentre study. Br J Dermatol 1997; 136: 89-93.
8. Louden BA, Pearce DJ, Lang W, Feldman SR. A simplified psoriasis area severity index (SPASI) for rating psoriasis severity in clinic patients. Dermatol Online J 2004; 10: 7.
9. Gardener MJ, Altman DG. Estimating with confidence. BMJ (Clin Res Ed) 1988; 296: 1210-1211.
10. Klaber MR, Hutchinson PE, Pedvis-Leftick A, Kragballe K, Reunala TL, Van de Kerkhof PCM, et al. Comparative effects of calcipitriol solution (50 μg/ml) and betamethasone 17-valerate solution (1 mg/ml) in the treatment of scalp psoriasis. Br J Dermatol 1994; 131: 678-683.